Search


Excellent questions. Brief response. Fine points about DTPA chelation.
Given the math of gadolinium retention - if a 72kg patient receives 14.4ml GBCA containing 7.7g MultiHance, and assuming 95% is removed...
Mar 24


Wendy Myers, ND interview with Richard Semelka, MD. on Gadolinium Toxicity on the Myers Detox Podcast. This is the state of the knowledge March 2025. This is the video production.
This is the video production so you can see us as we discuss Gadolinium Toxicity, GDD. The podcast manager Nicole for Dr. Wendy Myers ...
Mar 24


Calculating estimates for the amount of Gd that is permanently bound in the body, and cannot removed by chelation. Dr Semelka's opinions.
These are my estimates for the Gd retained in the body, with the final calculation of what is not susceptible to removal with chelation....
Mar 21


DTPA safety. Response to a Posting from Australia. This was describing Industrial use and not small volume Medical use.
On occasion, colleagues send me postings from Face Book or other social media sites, where something is written that has the potential to...
Mar 18


The wisdom of the middle path. In GBCAs and everything else.
History is replete with examples of groups taking an extreme untenable position and disaster follows. One example is the failure of the...
Mar 17


Something old, something new. Email exchange on Gd and introducing Platinum
A number of blogs are stimulated from email exchanges. This is one of them. This includes old points, that are worth repeating, and some...
Mar 15


Does oxalic acid disassemble all GBCAs in humans? I don't know, but I am doubtful
Wisdom comes with age in some, in many they just become old and crazier. Richard Semelka The team of Wagner recently published an...
Mar 13


Functional Genomics Analysis. Examination if there are consistent epigenetic, inflammogen, and other gene-related features consistent across GDD sufferers, Blog 2.
I am creating a second blog on this subject. In my estimation this genomic analysis may provide extremely useful information for the...
Mar 13


DTPA chelation in individuals with joint replacements, other metal implants, and particle disease. My theories.
This is an edited/ expanded version of a recent email response I made to a colleague who asked me about a patient with a cranial vessel...
Mar 12


Lysosomes, Solute carriers (SLC) and everything else. The more complicated the story, the more important to stick with basics. DTPA and steroids/antihistamines to treat Gadolinium Deposition Disease
THe more complicated the story becomes, the more critical it is to stick with the root cause. Trying to tackle individual disturbances/...
Mar 10